Viola, Kirsten L.
Sbarboro, James
Sureka, Ruchi
De, Mrinmoy
Bicca, Maíra A.
Wang, Jane
Vasavada, Shaleen
Satpathy, Sreyesh
Wu, Summer
Joshi, Hrushikesh
Velasco, Pauline T.
MacRenaris, Keith
Waters, E. Alex
Lu, Chang
Phan, Joseph
Lacor, Pascale
Prasad, Pottumarthi
Dravid, Vinayak P.
Klein, William L.
Article History
Received: 4 November 2013
Accepted: 8 October 2014
First Online: 22 December 2014
Competing interests
: This work was funded, in part, by Baxter Healthcare. Northwestern University holds the rights to two US and several international patents concerning antibodies that target Aβ oligomer assemblies. Acumen Pharmaceuticals holds the licensing rights to develop anti-Aβ oligomer antibodies for therapeutic use.